DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2b Trial of Halneuron® in CINP underway; Interim Results ...

In our SCN9A-targeted pain program, we have achieved robust and durable efficacy in a well-established rat model of chronic pain. These results fuel our commitment to diligently advancing these ...